BioxList.
Access 266 specialized US Biotech Venture Capital with our exclusive list. Actively funding therapeutics sectors including Gene Therapy, Cell Therapy, Small Molecules, Biologics, and more. This curated Excel/CSV database delivers actionable insights streamlined to essentials, including direct emails to 1500+ decision-makers for immediate outreach just data that converts.
Free your team to focus on what matters: your innovations.
What you will receive:
An Excel file for manual browsing and a CSV file packed with :
✅ a Direct Access to your future partner
1583 First-name contacts (Partners, Principals) at 266 U.S. Therapeutics VC firms – no assistants or generic addresses.
✅ a Match Perfectly with Your Needs
Pre-screened by active engagement in Seed to Series E rounds.
✅ a Full Portfolio Transparency
Access investor website URLs and active portfolio companies
✅ a Global Footprint Transparency
HQ locations + all operational countries.
Want an in-depth look at every data point? Click here to discover all the details.
Data freshness: Updated August 5 2025
Need specifics? Contact our data team here.
Data sourced from proprietary research
